Author

S. Gupta

Observed name: Santosh Gupta

Institution: Epic Sciences (United States)

Observed institution: Epic Sciences (United States)

ORCID: 0000-0002-5294-8245

Observed ORCID: 0000-0002-5294-8245

OpenAlex ID: A5070511810

Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)

2025 · Santosh Gupta, Siyuan Guo, et al. · Prostate Cancer and Prostatic Diseases · 1

1365P The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)

2022 · S. Gupta, Q. Yang, et al. · Annals of Oncology · 1

2394P Circulating tumour cell (CTC) characteristics associated with survival outcomes in metastatic castration-resistant prostate cancer (mCRPC) in a randomised trial of enzalutamide with or without [177Lu]Lu-PSMA-617 (ENZA-p; ANZUP 1901)

2025 · M. Crumbaker, S. Gupta, et al. · Annals of Oncology

Works count: 3

Citation count: 2

H-index: 1

I10-index: